Home  Clinical trials Products in Development ZD4054
|
|
A number of clinical trials with ZD4054 Ongoing studies are currently in progress.
More studies will be added in due course. Additional ZD4054 Ongoing study information is available on ClinicalTrials.gov. | Study Number | Study Phase | Start Date | Recruitment Status | | D4320C00017 | Phase I | 30 Jun 2008 | Recruiting | | A Phase I, Double-blind, Double-dummy, Placebo-controlled, Randomised, Four-period Crossover Study to Assess the Effects of Single Oral Doses of ZD4054 (10mg and 30mg) on QTc Interval Compared to Placebo, Using AVELOX (Moxifloxacin) as a Positive Control, in Healthy Volunteers Aged 18 to 45 Years. | | D4320C00025 | Phase II | 17 Apr 2008 | Recruiting | | An Open-label Comparative Study of the Pharmacokinetics, Safety and Tolerability of ZD4054 following a 10 mg Single Oral Dose of ZD4054 to Healthy Subjects and to Subjects with Mild, Moderate and Severe Hepatic Impairment | | D4320C00029 | Phase I | 19 Jun 2008 | Active, not recruiting | | A Phase I, Randomised, Single-blind, Single-centre, Incomplete-block Crossover, Relative Bioavailability Study in Healthy Male Subjects for ZD4054 Immediate Release Tablets |
|
|
|
|